Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer
Clinical trial NCT02923921 · COMPLETED
Trial details
- NCT number
- NCT02923921
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2019-09-09
- Enrollment
- 567
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.